Clinical Outcomes From NOCD Digital Behavioral Health Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention

NOCD1 site in 1 country2,069 target enrollmentJanuary 1, 2020

ConditionsObsessive-Compulsive Disorder

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Obsessive-Compulsive Disorder
Sponsor: NOCD
Enrollment: 2069
Locations: 1
Primary Endpoint: Dimensional Obsessive-Compulsive Scale
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This is a naturalistic, observational study of individuals with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy, augmented with between-session support with text messaging and an online community forum.

Registry

clinicaltrials.gov

Start Date

January 1, 2020

End Date

November 8, 2020

Last Updated

5 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

NOCD

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•obsessive-compulsive disorder

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Dimensional Obsessive-Compulsive Scale

Time Frame: change from pre-treatment to post-treatment (after 11 weeks)

self-rated psychometric instrument to measure symptom severity of multiple OCD subtypes

Secondary Outcomes

Depression Anxiety and Stress Scale (DASS-21)(pre-treatment, after 4 weeks, and post-treatment (after 11 weeks))
Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND) OCD severity scale(pre-treatment, after 4 weeks, and post-treatment (after 11 weeks))
Quality of Life Enjoyment and Satisfaction Questionnaire -- Short Form (QLES-Q)(pre-treatment, after 4 weeks, and post-treatment (after 11 weeks))